As the Covid-19 pandemic rages, Peloton’s stock surges and the company scrambles to keep up with the new demand for its products. They pour millions of dollars into increasing production and cutting down on shipping time. But when tragedy strikes, Peloton’s newfound popularity takes a hit. And soon, it's an open question if the company can survive on its own ... Show More
Oct 2025
The Rise and Fall of Peloton | Pedal On | 3
Peloton’s pandemic hype and sales have died down and now, the company must determine what’s next. Lauren Thomas of the Wall Street Journal talks to us about what it’ll take for Peloton to continue as a standalone company. Later, we’re talking to fitness creator Cassey Ho, who fou ... Show More
42m 4s
Oct 2025
How Lululemon Won Athleisure | Mirror, Mirror | 2
It's the 2010s, and the athleisure market has exploded. As Lululemon has grown into one of the world's biggest athletic wear companies, brands like Nike and Adidas want a piece of the pie—and new, smaller companies are adding to the competition. Soon, everyone will be selling the ... Show More
33 m
Nov 2021
Rapid Response: How Peloton keeps pushing through resistance, w/CEO John Foley
Skepticism and doubt are no strangers to John Foley, the CEO of Peloton. As he says, it’s been part of the company’s DNA “since the first time I pitched the business to an investor back in 2012.” Last year, the company was supercharged by pandemic demand. However, in 2021, the co ... Show More
31m 1s
Feb 2022
Peloton’s turmoil could be appealing
<p>Dozens of biotech companies are running low on cash and face an uphill struggle to raise fresh funds, Fidelity’s little-known passive investment business Geode Capital Management surged to $1tn in assets last year. Plus, the FT’s US business editor, Andrew Edgecliffe-John ... Show More
9m 35s